Lataa...
Seamless Phase I–II Trial Design for Assessing Toxicity and Efficacy for Targeted Agents
PURPOSE: The premise for phase I trials for cytostatic agents is different from that of cytotoxic agents. For cytostatic agents, toxicity and efficacy do not necessarily increase monotonically with increasing dose levels, but likely plateau after they reach maximal toxicity or efficacy. Here, we pro...
Tallennettuna:
| Julkaisussa: | Clin Cancer Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4391513/ https://ncbi.nlm.nih.gov/pubmed/21135145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-1262 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|